DR. ALLEN L COHN, MD
Osteopathic Medicine at Williams St, Denver, CO
License number
Colorado 27525
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
2
1800 Williams St SUITE 200, Denver, CO 80218
7951 E Maplewood Ave STE 300, Englewood, CO 80111
7951 E Maplewood Ave STE 300, Englewood, CO 80111
Phone
(303) 388-4876
(303) 285-5097 (Fax)
(303) 930-7800
(303) 930-7860 (Fax)
(303) 285-5097 (Fax)
(303) 930-7800
(303) 930-7860 (Fax)
Personal information
See more information about ALLEN L COHN at radaris.comName
Address
Phone
10460 E Aberdeen Ave, Englewood, CO 80111
10460 Aberdeen Ave, Englewood, CO 80111
4701 9Th Ave, Denver, CO 80220
1800 Williams St, Denver, CO 80218
4500 9Th Ave, Denver, CO 80220
Organization information
See more information about ALLEN L COHN at bizstanding.comRMCC Mid Town - Scott I Bearman MD
1800 Williams St STE 200, Denver, CO 80218
Doing business as:
RMCC Mid Town - Ioana M Hinshaw MD<br>RMCC Mid Town - Robert M Jotte MD<br>RMCC Mid Town - Allen L Cohn MD
Phone:
(303) 388-4876 (Phone)
Categories:
Hematology Physicians & Surgeons, Internal Medicine Physicians & Surgeons, Oncology Physicians & Surgeons, ...
Specialties:
Cancer Oncology
Products:
Advancing Cancer Care., Chemotherapy, Clinical Research, ...
Additional:
Inspiring Hope., Blood & Marrow Transplant Program, Mobile Pet CT
Rocky Mountain Cancer Center - Allen L Cohn MD
4700 Hale Pkwy STE 400, Denver, CO 80220
Categories:
Oncology Physicians & Surgeons, Physicians & Surgeons
Phone:
(303) 321-0302 (Phone)
Professional information
Dr. Allen L Cohn - MD (Doctor of Medicine)
Hospitals:
Rocky Mountain Cancer Centers
1800 Williams St SUITE 200, Denver 80218
Rocky Mountain Cancer Centers
4700 Hale Pkwy SUITE 400, Denver 80220
Presbyterian/Saint Luke's Medical Center
1719 East 19Th Ave, Denver 80218
Rose Medical Center
4567 East 9Th Ave, Denver 80220
Sky Ridge Medical Center
10101 Rdg Gate Pkwy, Lone Tree 80124
Rocky Mountain Cancer Centers
1800 Williams St SUITE 200, Denver 80218
Rocky Mountain Cancer Centers
4700 Hale Pkwy SUITE 400, Denver 80220
Presbyterian/Saint Luke's Medical Center
1719 East 19Th Ave, Denver 80218
Rose Medical Center
4567 East 9Th Ave, Denver 80220
Sky Ridge Medical Center
10101 Rdg Gate Pkwy, Lone Tree 80124
1800 Williams St SUITE 200, Denver 80218
Rocky Mountain Cancer Centers
4700 Hale Pkwy SUITE 400, Denver 80220
Presbyterian/Saint Luke's Medical Center
1719 East 19Th Ave, Denver 80218
Rose Medical Center
4567 East 9Th Ave, Denver 80220
Sky Ridge Medical Center
10101 Rdg Gate Pkwy, Lone Tree 80124
Rocky Mountain Cancer Centers
1800 Williams St SUITE 200, Denver 80218
Rocky Mountain Cancer Centers
4700 Hale Pkwy SUITE 400, Denver 80220
Presbyterian/Saint Luke's Medical Center
1719 East 19Th Ave, Denver 80218
Rose Medical Center
4567 East 9Th Ave, Denver 80220
Sky Ridge Medical Center
10101 Rdg Gate Pkwy, Lone Tree 80124
Education:
Medical Schools
University Of Maryland Medical System
Graduated: 1985
University Of Maryland Medical System
Graduated: 1985
Allen L Cohn, Denver CO
Specialties:
Oncologist
Address:
4500 E 9Th Ave, Denver, CO 80220
Education:
University of Maryland, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Md At Rmcc
Position:
md at rmcc
Location:
Greater Denver Area
Industry:
Hospital & Health Care
Work:
rmcc
-
md
Education:
md
Allen Cohn, Denver CO
Work:
Rocky Mountain Cancer Ctr
1800 Williams St, Denver, CO 80218 Rocky Mountain Cancer Ctr
4700 Hale Pkwy, Denver, CO 80220 Yampa Valley Medical Ctr
1024 Central Park Dr, Steamboat Springs, CO 80487
1800 Williams St, Denver, CO 80218 Rocky Mountain Cancer Ctr
4700 Hale Pkwy, Denver, CO 80220 Yampa Valley Medical Ctr
1024 Central Park Dr, Steamboat Springs, CO 80487
Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration
US Patent:
8273789, Sep 25, 2012
Filed:
Sep 1, 2010
Appl. No.:
12/873477
Inventors:
James D. McChesney - Etta MS, US
Gilles Tapolsky - Boulder CO, US
David L. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Hawthorne NY, US
Allen Cohn - Denver CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
Gilles Tapolsky - Boulder CO, US
David L. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Hawthorne NY, US
Allen Cohn - Denver CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
Assignee:
Tapestry Pharmaceuticals, Inc. - Boulder CO
International Classification:
A61K 31/35, A61K 31/335, C07D 309/00, C07D 407/00
US Classification:
514453, 514357, 514449, 549510, 549511, 549357, 549358
Abstract:
The present invention relates to a novel chemical compound of formula S-(1):.
Taxane Analogs For The Treatment Of Brain Cancer
US Patent:
8409574, Apr 2, 2013
Filed:
Aug 20, 2010
Appl. No.:
12/859990
Inventors:
James D. McChesney - Etta MS, US
Gilles Tapolsky - Boulder CO, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Briarcliff Manor NY, US
Allen Cohn - Englewood CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
Gilles Tapolsky - Boulder CO, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Briarcliff Manor NY, US
Allen Cohn - Englewood CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
International Classification:
A61K 39/00, A61K 31/415, A61K 31/335, A01N 43/52, A01N 43/32, C07D 309/00
US Classification:
4241331, 514393, 514452, 549358
Abstract:
Provided herein are compounds and methods for the treatment of brain cancer in a mammal, wherein the method comprises the administration to the mammal a compound that stabilizes tubulin dimers or microtubles at G2-M interface during mitosis but is not a substrate for MDR protein. In particular, the present application relates to the use of an orally effective abeo-taxane, alone or in combination with temozolomide or bevacizumab, for the treatment of brain cancer.
Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration
US Patent:
8552056, Oct 8, 2013
Filed:
Sep 15, 2012
Appl. No.:
13/620852
Inventors:
James D. McChesney - Etta MS, US
Gilles Tapolsky - Boulder CO, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Hawthorne NY, US
Allen Cohn - Denver CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
Gilles Tapolsky - Boulder CO, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Hawthorne NY, US
Allen Cohn - Denver CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
Assignee:
Tapestry Pharmaceuticals, Inc. - Boulder CO
International Classification:
A61K 31/335, A61K 31/44, C07D 407/00, C07D 309/00
US Classification:
514449, 514357, 549510, 549511, 549357, 549358
Abstract:
The present invention relates to a novel chemical compound of formula S-(1):.
Taxane Analogs For The Treatment Of Brain Cancer
US Patent:
2013025, Sep 26, 2013
Filed:
Mar 5, 2013
Appl. No.:
13/785753
Inventors:
Gilles Tapolsky - Louisville KY, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Briarcliff Manor NY, US
Allen Cohn - Englewood CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
David E. Emerson - Longmont CO, US
John Marshall - Washington DC, US
Tauseef Ahmed - Briarcliff Manor NY, US
Allen Cohn - Englewood CO, US
Michael Kurman - Upper Saddle River NJ, US
Manuel Modiano - Tucson AZ, US
International Classification:
A61K 31/357
US Classification:
514452, 549358
Abstract:
Provided herein are compounds and methods for the treatment of brain cancer in a mammal, wherein the method comprises the administration to the mammal a compound that stabilizes tubulin dimers or microtubles at G2-M interface during mitosis but is not a substrate for MDR protein. In particular, the present application relates to the use of an orally effective abeo-taxane, alone or in combination with temozolomide or bevacizumab, for the treatment of brain cancer.